Janssen Switzerland’s Ludo Ooms highlights the strengths of the Swiss healthcare and life sciences sector including the efficiency of the government, a productive and well trained workforce, the national pricing system, and the climate for innovation; all factors which make Switzerland a strategic market for Johnson & Johnson and Janssen.
What is the baseline strategy for Janssen in Switzerland? You are responsible for two different systems, the Austrian and the Swiss, so are your strategies cohesive? What are the key pillars?
Johnson & Johnson and Janssen are deeply engrained in Switzerland
